- Capital Cube•2 months ago
IntelGenx Technologies Corp. relative valuation is OVERVALUED and it has a fundamental analysis score of 94.Our analysis is based on comparing IntelGenx Technologies Corp. with the following peers – Valeant Pharmaceuticals International, Inc., EnWave Corporation, Sirona Biochem Corp., Telesta Therapeutics Inc., Vitality Products Inc. and Intellipharmaceutics International Inc. (VRX-CA, ENW-CA, SBM-CA, TST-CA, VPI-CA and I-CA).IntelGenx […] (Read more...) The post IntelGenx Technologies Corp.: Leads amongst peers with strong fundamentals appeared first on CapitalCube.
- Associated Press•3 months ago
The Ville Saint Laurent, Quebec-based company said it had a loss of 1 cent per share. The drug delivery technology company posted revenue of $818,000 in the period. In the final minutes of trading on Tuesday, ...
|52wk Range||0.54 - 0.85|
|Day's Range||0.72 - 0.72|
|Avg Vol (3m)||5,188|
As of 3:05 PM EDT. Market closed.